Michael Patrick Miller has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, PUMA BIOTECHNOLOGY, INC., BioXcel Therapeutics, Inc., VIVUS INC, CONNETICS CORP, and RIGEL PHARMACEUTICALS INC.
2005 was Michael Patrick Miller's most active year for acquiring shares with 12 total transactions. Michael Patrick Miller's most active month to acquire stocks was the month of May. 2005 was Michael Patrick Miller's most active year for disposing of shares, totalling 21 transactions. Michael Patrick Miller's most active month to dispose stocks was the month of May. 2005 saw Michael Patrick Miller paying a total of $1,703,250.00 for 95,000 shares, this is the most they've acquired in one year. In 2012 Michael Patrick Miller cashed out on 150,000 shares for a total of $2,085,900.00, their largest year based on trade value.